CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
Carbocisteine

羧甲司坦 杂质对照品Carbocisteine Impurities

36 个杂质条目36 impurity entries

本页汇总 羧甲司坦 的 36 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 36 impurity reference standards of Carbocisteine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 羧甲司坦(Carbocisteine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIdentification of low-level impurities in drug prototypes of carbocisteine by means of liquid chromatography-high-resolution mass spectrometry and general unknown comparative screening
    Journal of chromatography. A · 2023 · Walther R et al.  ·  PMID 37586140  ·  DOI
  2. 杂质研究Impurity studiesImpurity profiling of carbocisteine by HPLC-CAD, qNMR and UV/vis spectroscopy
    Journal of pharmaceutical and biomedical analysis · 2014 · Wahl O, Holzgrabe U  ·  PMID 24637049  ·  DOI
  3. 分析方法Analytical MethodsA New Fluorescence Probe for the Quantification of Acetylcysteine and Carbocisteine in Bulk and Spiked Urine: Greenness Appraisal by Exploiting Different GAC-Metric Strategies
    Luminescence : the journal of biological and chemical luminescence · 2025 · Elbardisy HM et al.  ·  PMID 39805631  ·  DOI
  4. 分析方法Analytical MethodsBioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
    Scientia pharmaceutica · 2014 · Dhanure S et al.  ·  PMID 26171322  ·  DOI
  5. 分析方法Analytical MethodsIon-chromatographic determination of carbocisteine in pharmaceuticals based on non-suppressed conductimetric detection
    Journal of chromatography. A · 2004 · Megoulas NC, Koupparis MA  ·  PMID 14763743  ·  DOI

羧甲司坦 —— 原料药与杂质对照品Carbocisteine — drug substance & impurities

共 37 个条目(含原料药本体)37 items incl. the drug substance
Carbocisteine structure
原料药 APIAPI
羧甲司坦Carbocisteine
Carbocisteine
CAS No.638-23-3
Chemical FormulaC5H9NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 1 structure
1
羧甲司坦杂质1Carbocisteine Impurity 1
Carbocisteine Impurity 1
CAS No.2820941-84-0
Chemical FormulaC7H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity N1 structure
N1
羧甲司坦杂质N1Carbocisteine Impurity N1
Carbocisteine Impurity N1
CAS No.31898-75-6
Chemical FormulaC5H7NO3S
Purity>95%现货In stock
10mg25mg50mg100mg
Carbocisteine Impurity 2 (Carbocisteine S-Oxide) structure
2
羧甲司坦杂质2 (羧甲司坦硫氧化物)Carbocisteine Impurity 2 (Carbocisteine S-Oxide)
Carbocisteine Impurity 2 (Carbocisteine S-Oxide)
CAS No.5439-87-2
Chemical FormulaC5H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 3 ((S)-Carbocisteine) structure
3
羧甲司坦杂质3 ((S)-羧甲司坦)Carbocisteine Impurity 3 ((S)-Carbocisteine)
Carbocisteine Impurity 3 ((S)-Carbocisteine)
CAS No.50698-76-5
Chemical FormulaC5H9NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 4 structure
4
羧甲司坦杂质4Carbocisteine Impurity 4
Carbocisteine Impurity 4
CAS No.88620-38-6
Chemical FormulaC5H7NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 5 structure
5
羧甲司坦杂质5Carbocisteine Impurity 5
Carbocisteine Impurity 5
CAS No.15253-37-9
Chemical FormulaC5H9NO4S2
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 6 structure
6
羧甲司坦杂质6Carbocisteine Impurity 6
Carbocisteine Impurity 6
CAS No.118573-75-4
Chemical FormulaC5H7NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 7 structure
7
羧甲司坦杂质7Carbocisteine Impurity 7
Carbocisteine Impurity 7
CAS No.118492-49-2
Chemical FormulaC5H7NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 8 structure
8
羧甲司坦杂质8Carbocisteine Impurity 8
Carbocisteine Impurity 8
CAS No.62305-89-9
Chemical FormulaC5H7NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 8 Sodium Salt structure
8
羧甲司坦杂质8钠盐Carbocisteine Impurity 8 Sodium Salt
Carbocisteine Impurity 8 Sodium Salt
CAS No.88933-48-6
Chemical FormulaC5H6NNaO3S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 9 structure
9
羧甲司坦杂质9Carbocisteine Impurity 9
Carbocisteine Impurity 9
CAS No.14226-97-2
Chemical FormulaC5H7NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 12 structure
12
羧甲司坦杂质12Carbocisteine Impurity 12
Carbocisteine Impurity 12
CAS No.756761-90-7
Chemical FormulaC9H13NO8S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 13 structure
13
羧甲司坦杂质13Carbocisteine Impurity 13
Carbocisteine Impurity 13
CAS No.1601460-92-7
Chemical FormulaC7H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 14 structure
14
羧甲司坦杂质14Carbocisteine Impurity 14
Carbocisteine Impurity 14
CAS No.112246-66-9
Chemical FormulaC5H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 15 structure
15
羧甲司坦杂质15Carbocisteine Impurity 15
Carbocisteine Impurity 15
CAS No.87862-95-1
Chemical FormulaC5H7NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 16 structure
16
羧甲司坦杂质16Carbocisteine Impurity 16
Carbocisteine Impurity 16
CAS No.61475-35-2
Chemical FormulaC5H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 20 structure
20
羧甲司坦杂质20Carbocisteine Impurity 20
Carbocisteine Impurity 20
CAS No.4271-36-7
Chemical FormulaC6H12N2O5S
Purity>95%现货In stock
10mg25mg50mg100mg
Carbocisteine Impurity 21 structure
21
羧甲司坦杂质21Carbocisteine Impurity 21
Carbocisteine Impurity 21
CAS No.21885-10-9
Chemical FormulaC5H9NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 23 structure
23
羧甲司坦杂质23Carbocisteine Impurity 23
Carbocisteine Impurity 23
CAS No.907565-13-3
Chemical FormulaC7H11NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 29 structure
29
羧甲司坦杂质29Carbocisteine Impurity 29
Carbocisteine Impurity 29
CAS No.92282-33-2
Chemical FormulaC9H17NO4S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 30 structure
30
羧甲司坦杂质30Carbocisteine Impurity 30
Carbocisteine Impurity 30
CAS No.792135-12-7
Chemical FormulaC11H21NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 33 structure
33
羧甲司坦杂质33Carbocisteine Impurity 33
Carbocisteine Impurity 33
CAS No.60115-66-4
Chemical FormulaC7H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 42 structure
42
羧甲司坦杂质42Carbocisteine Impurity 42
Carbocisteine Impurity 42
CAS No.23255-15-4
Chemical FormulaC8H15NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 43 structure
43
羧甲司坦杂质43Carbocisteine Impurity 43
Carbocisteine Impurity 43
CAS No.25390-17-4
Chemical FormulaC5H9NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 46 structure
46
羧甲司坦杂质46Carbocisteine Impurity 46
Carbocisteine Impurity 46
CAS No.33163-97-2
Chemical FormulaC5H7NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 47 structure
47
羧甲司坦杂质47Carbocisteine Impurity 47
Carbocisteine Impurity 47
CAS No.151756-26-2
Chemical FormulaC5H9NO4S·C6H14N2O2·H2O
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 48 structure
48
羧甲司坦杂质48Carbocisteine Impurity 48
Carbocisteine Impurity 48
CAS No.92846-93-0
Chemical FormulaC11H11N3O9S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 49 structure
49
羧甲司坦杂质49Carbocisteine Impurity 49
Carbocisteine Impurity 49
CAS No.2642174-84-1
Chemical FormulaC7H9NO5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 52 structure
52
羧甲司坦杂质52Carbocisteine Impurity 52
Carbocisteine Impurity 52
CAS No.103669-43-8
Chemical FormulaC8H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 53 structure
53
羧甲司坦杂质53Carbocisteine Impurity 53
Carbocisteine Impurity 53
CAS No.37486-49-0
Chemical FormulaC5H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 54 structure
54
羧甲司坦杂质54Carbocisteine Impurity 54
Carbocisteine Impurity 54
CAS No.105983-84-4
Chemical FormulaC13H25NO5
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 60 structure
60
羧甲司坦杂质60Carbocisteine Impurity 60
Carbocisteine Impurity 60
CAS No.119437-71-7
Chemical FormulaC10H16N2O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 61 structure
61
羧甲司坦杂质61Carbocisteine Impurity 61
Carbocisteine Impurity 61
CAS No.82951-55-1
Chemical FormulaC11H21N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 66 structure
66
羧甲司坦杂质66Carbocisteine Impurity 66
Carbocisteine Impurity 66
CAS No.1268868-51-4
Chemical FormulaC7H9NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 67 structure
67
羧甲司坦杂质67Carbocisteine Impurity 67
Carbocisteine Impurity 67
CAS No.25515-73-5
Chemical FormulaC5H9NO6S
Purity>95%询价On request
10mg25mg50mg100mg
Carbocisteine Impurity 68 structure
68
羧甲司坦杂质68Carbocisteine Impurity 68
Carbocisteine Impurity 68
CAS No.2464-23-5
Chemical FormulaC3H4O3S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

羧甲司坦 —— 研究文献与合成路线Carbocisteine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 羧甲司坦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Carbocisteine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Impurity profiling of carbocisteine by HPLC-CAD, qNMR and UV/vis spectroscopy
    Wahl O, Holzgrabe U · Journal of pharmaceutical and biomedical analysis · 2014 · 被引 11cited 11
  2. Identification of low-level impurities in drug prototypes of carbocisteine by means of liquid chromatography-high-resolution mass spectrometry and general unknown comparative screening
    Walther R, Kinzig M, Zamponi A, et al. · Journal of chromatography. A · 2023 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. Synthesis and biological evaluation of an anticancer drug delivery system: Poly(l-γ-glutamyl-l-carbocisteine)-paclitaxel nanoconjugate
    Han L, Xiao Y, Fan M, et al. · Materials science & engineering. C, Materials for biological applications · 2017

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

羧甲司坦 杂质谱研究要点Carbocisteine — impurity profiling notes

下面这些是拿到 羧甲司坦 的 37 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 37 impurity entries for Carbocisteine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances